1. Home
  2. HQY vs KRYS Comparison

HQY vs KRYS Comparison

Compare HQY & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

HOLD

Current Price

$82.25

Market Cap

7.0B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$308.98

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQY
KRYS
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.8B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
HQY
KRYS
Price
$82.25
$308.98
Analyst Decision
Buy
Strong Buy
Analyst Count
14
11
Target Price
$115.00
$297.60
AVG Volume (30 Days)
785.1K
276.0K
Earning Date
06-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
125.69
128.00
EPS
2.46
1.83
Revenue
$229,525,000.00
$389,130,000.00
Revenue This Year
$8.57
$38.74
Revenue Next Year
$8.42
$32.53
P/E Ratio
$33.32
$172.44
Revenue Growth
28.68
33.94
52 Week Low
$72.76
$123.03
52 Week High
$116.65
$319.48

Technical Indicators

Market Signals
Indicator
HQY
KRYS
Relative Strength Index (RSI) 49.41 65.82
Support Level $80.00 $253.89
Resistance Level $84.21 N/A
Average True Range (ATR) 2.33 12.66
MACD -0.12 3.09
Stochastic Oscillator 48.93 82.09

Price Performance

Historical Comparison
HQY
KRYS

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: